Literature DB >> 15528744

Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada.

Raymond S W Tsang1, Allan K H Lau, Michelle L Sill, Scott A Halperin, Paul Van Caeseele, Frances Jamieson, Irene E Martin.   

Abstract

The fim genes which code for the fimbria protective antigens present in both the inactivated whole-cell and acellular vaccines were analyzed in 86 Canadian Bordetella pertussis isolates. At least one of the novel mutations identified was found to involve a surface epitope that has been mapped by serum antibodies from infected or vaccinated subjects.

Mesh：

Substances：

Year:  2004        PMID： 15528744      PMCID： PMC525145          DOI： 10.1128/JCM.42.11.5364-5367.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  23 in total

1.  Use of pertussis toxin encoded by ptx genes from Bordetella bronchiseptica to model the effects of antigenic drift of pertussis toxin on antibody neutralization.

Authors:  S Z Hausman; D L Burns
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

2.  Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years.

Authors:  C Weber; C Boursaux-Eude; G Coralie; V Caro; N Guiso
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

3.  Thirty-five years' experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicity.

Authors:  E Njamkepo; F Rimlinger; S Thiberge; Nicole Guiso
Journal:  Vaccine       Date:  2002-01-31       Impact factor: 3.641

4.  Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland.

Authors:  A Gzyl; E Augustynowicz; I van Loo; J Slusarczyk
Journal:  Vaccine       Date:  2001-11-12       Impact factor: 3.641

5.  Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom.

Authors:  N K Fry; S Neal; T G Harrison; E Miller; R Matthews; R C George
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

6.  Analysis of Bordetella pertussis isolates collected in Japan before and after introduction of acellular pertussis vaccines.

Authors:  N Guiso; C Boursaux-Eude; C Weber; S Z Hausman; H Sato; M Iwaki; K Kamachi; T Konda; D L Burns
Journal:  Vaccine       Date:  2001-04-30       Impact factor: 3.641

7.  Multilocus sequence typing of Bordetella pertussis based on surface protein genes.

Authors:  Inge H M van Loo; Kees J Heuvelman; Audrey J King; Frits R Mooi
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

8.  Whooping cough--a continuing problem.

Authors:  N S Crowcroft; Joseph Britto
Journal:  BMJ       Date:  2002-06-29

9.  Bordetella pertussis in the National Capital Region: prevalent serotype and immunization status of patients.

Authors:  E Rossier; F Chan
Journal:  Can Med Assoc J       Date:  1977-11-19       Impact factor: 8.262

10.  Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine.

Authors:  C Boursaux-Eude; S Thiberge; G Carletti; N Guiso
Journal:  Vaccine       Date:  1999-06-04       Impact factor: 3.641
View more
  27 in total

Review 1.  The Bordetella pertussis model of exquisite gene control by the global transcription factor BvgA.

Authors:  Kimberly B Decker; Tamara D James; Scott Stibitz; Deborah M Hinton
Journal:  Microbiology       Date:  2012-05-24       Impact factor: 2.777

2.  Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia, and vaccine strains.

Authors:  Olga Borisova; Svetlana Yu Kombarova; Nelli S Zakharova; Marjolein van Gent; Vladimir A Aleshkin; Isabella Mazurova; Frits R Mooi
Journal:  Clin Vaccine Immunol       Date:  2007-01-03

3.  Pertussis in rural populations of Saskatchewan (1995 to 2003): incidence, seasonality, and differences among cases.

Authors:  David Vickers; Raúl C Mainar-Jaime; Punam Pahwa
Journal:  Can J Public Health       Date:  2006 Nov-Dec

4.  Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis.

Authors:  Hans Hallander; Abdolreza Advani; Marion Riffelmann; Carl H W von König; Valerie Caro; Nicole Guiso; Frits R Mooi; Anna Gzyl; Margit S Kaltoft; Norman K Fry; Jussi Mertsola; Qiushui He
Journal:  J Clin Microbiol       Date:  2007-08-15       Impact factor: 5.948

5.  Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type.

Authors:  David J Litt; Shona E Neal; Norman K Fry
Journal:  J Clin Microbiol       Date:  2009-01-21       Impact factor: 5.948

6.  Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model.

Authors:  Eiji Komatsu; Fuminori Yamaguchi; Akio Abe; Alison A Weiss; Mineo Watanabe
Journal:  Clin Vaccine Immunol       Date:  2010-03-31

7.  Strain variation among Bordetella pertussis isolates circulating in Poland after 50 years of whole-cell pertussis vaccine use.

Authors:  Ewa Mosiej; Ewa Augustynowicz; Monika Zawadka; Waldemar Dabrowski; Anna Lutyńska
Journal:  J Clin Microbiol       Date:  2011-02-09       Impact factor: 5.948

8.  Short-Read Whole-Genome Sequencing for Laboratory-Based Surveillance of Bordetella pertussis.

Authors:  Alex Marchand-Austin; Raymond S W Tsang; Jennifer L Guthrie; Jennifer H Ma; Gillian H Lim; Natasha S Crowcroft; Shelley L Deeks; David J Farrell; Frances B Jamieson
Journal:  J Clin Microbiol       Date:  2017-02-22       Impact factor: 5.948

9.  Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009.

Authors:  Abdolreza Advani; Hans O Hallander; Tine Dalby; Karen Angeliki Krogfelt; Nicole Guiso; Elisabeth Njamkepo; Carl Heinz Wirsing von Könnig; Marion Riffelmann; Frits R Mooi; Per Sandven; Anna Lutynska; Norman K Fry; Jussi Mertsola; Qiushui He
Journal:  J Clin Microbiol       Date:  2012-11-21       Impact factor: 5.948

10.  Production and characterization of recombinant pertactin, fimbriae 2 and fimbriae 3 from Bordetella pertussis.

Authors:  Yinghua Xu; Yaying Wang; Yajun Tan; Huajie Zhang; Lijie Wu; Lichan Wang; Qiming Hou; Shumin Zhang
Journal:  BMC Microbiol       Date:  2009-12-29       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.